|
FY2026
12 months to Mar 31, 2026
|
FY2025
12 months to Mar 31, 2025
|
FY2024
12 months to Mar 31, 2024
|
FY2023
12 months to Mar 31, 2023
|
FY2022
11 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Flows from Operating Activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net income to net cash used in operating activities: | |||||
| Interest and dividend income on investments held in trust account | |||||
| Change in fair value of warrant liability | |||||
| Changes in operating assets and liabilities: | |||||
| Prepaid expenses | |||||
| Prepaid franchise taxes | |||||
| Other receivable | |||||
| Accounts payable and accrued expenses | |||||
| Excise tax paid | |||||
| Income tax payable | |||||
| Net cash used in operating activities | |||||
| Cash Flows from Investing Activities: | |||||
| Cash advanced to target company | |||||
| Cash deposited in Trust Account | |||||
| Cash withdrawn from trust account to pay franchise tax | |||||
| Cash withdrawn from trust account in connection with redemption | |||||
| Net cash (used in) provided by investing activities | |||||
| Cash Flows from Financing Activities: | |||||
| Proceeds from loan - JC Unify | |||||
| Proceeds from promissory note - Wei-Hua Chang | |||||
| Advance from Prior Sponsor | |||||
| Redemption of common stock | |||||
| Net cash provided by (used in) financing activities | |||||
| Net Change in Cash | |||||
| Cash - Beginning of period | |||||
| Cash - End of period | |||||
| Accretion of Public Shares to redemption value | |||||
| Non-cash investing and financing activities | |||||
| Accretion of Public Shares to redemption value | |||||
Loading...